Daiichi Sankyo Unit Sues to Block 2 Nutrition Shot Copies (1)

Feb. 23, 2024, 7:37 PM UTCUpdated: Feb. 23, 2024, 8:16 PM UTC

Daiichi Sankyo Inc.’s American Regent unit filed separate lawsuits alleging that Somerset Pharma LLC’s proposed copies of two nutritional supplements that deliver essential trace elements via injections to patients who can’t eat normally infringe a patent issued last October.

American Regent Inc. in one suit seeks an order blocking Somerset’s proposed generic version of Tralement; in the other suit, it seeks a permanent injunction blocking its proposed copy of Multrys, according to complaints filed Thursday in the US District Court for the District of New Jersey. It then filed two complaints against Somerset over Tralement and Multrys on Friday ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.